What is the serial number for INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE?

The USPTO serial number for INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE is 98638765.

What is the registration number for INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE?

INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE is registered under USPTO registration number 8267176.

INT

USPTO Trademark Record

REGISTERED

INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE

Q: Who owns the INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark?

The INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark is owned by The Ovarian Cancer Research Fund, Inc..

Q: What class is the INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark registered in?

The INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark is registered in Class 035 (Advertising, business management & retail services), Class 038 (Telecommunications services), Class 041 (Education & entertainment services).

SN 98638765·Reg 8267176·Filed Jul 09, 2024

Owner The Ovarian Cancer Research Fund, Inc.

Advertising; business management, organization and administration; office functions.; Telecommunications.; Education; providing of training; entertainment; sporting and cultural activities.

INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE (Serial No. 98638765), Registration No. 8267176, is a registered US trademark filed on Jul 09, 2024 by The Ovarian Cancer Research Fund, Inc.. This trademark covers Class 035 (Advertising, business management & retail services), Class 038 (Telecommunications services), Class 041 (Education & entertainment services).

early section 8: May 19, 2032

Mark Intelligence

INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE (Reg. #8267176) is a registered US trademark that has been protecting its owner, The Ovarian Cancer Research Fund, Inc., since 2024. The mark covers Class 035 (Advertising, business management & retail services), Class 038 (Telecommunications services) and Class 041 (Education & entertainment services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Telecommunications.; Education; pr....

FILED

Jul 09, 2024

SERIAL

98638765

REG#

8267176

REGISTERED

May 19, 2026

Owner

Applicant

The Ovarian Cancer Research Fund, Inc.

Entity

Not Provided

State

Address

45 Rockefeller Plaza, 20th Floor, New York, NY, 10111

Country

Attorney

NamePaul C. Llewellyn

Law firm

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

Docket

1046134.0003

Address

601 Massachusetts Ave., NW, Washington, DC 20001, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 09, 2024

Serial Number98638765

Registration No.8267176

Registration DateMay 19, 2026

Status DateMay 19, 2026

Mark TypeStandard characters

Attorney Docket1046134.0003

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Jun 18, 2024

First use in commerce: Jun 18, 2024

Advertising; business management, organization and administration; office functions.

Class 038Telecommunications services

US codes: 100, 101, 104

First use anywhere: Jun 18, 2024

First use in commerce: Jun 18, 2024

Telecommunications.

Class 041Education & entertainment services

US codes: 100, 101, 107

First use anywhere: Jun 18, 2024

First use in commerce: Jun 18, 2024

Education; providing of training; entertainment; sporting and cultural activities.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

33 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 17, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 17, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 17, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 17, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 17, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-SUPPLEMENTAL REGISTER

May 19, 2026

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 19, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 19, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Apr 18, 2026

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 16, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 16, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 16, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Apr 15, 2026

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Apr 15, 2026

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Apr 15, 2026

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Apr 15, 2026

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

USE AMENDMENT ACCEPTED

Mar 31, 2026

USE AMENDMENT ACCEPTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 08, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 08, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 08, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Oct 08, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 20, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS AMENDMENT OF USE RECEIVED

Aug 20, 2025

TEAS AMENDMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 20, 2025

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Aug 20, 2025

AMENDMENT TO USE PROCESSING COMPLETE

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 02, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 02, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Feb 21, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 21, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 21, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 01, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 31, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 09, 2024

NEW APPLICATION ENTERED

INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by The Ovarian Cancer Research Fund, Inc.

Other Marks in Class 035 — Advertising, business management & retail services

Other Marks by Paul C. Llewellyn

Resources

Company